These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 31686580)
1. Alfranca G; Beola L; Liu Y; Gutiérrez L; Zhang A; Artiga A; Cui D; de la Fuente JM Nanomedicine (Lond); 2019 Dec; 14(23):3035-3055. PubMed ID: 31686580 [No Abstract] [Full Text] [Related]
2. Biodistribution of colloidal gold nanoparticles after intravenous injection: Effects of PEGylation at the same particle size. Takeuchi I; Onaka H; Makino K Biomed Mater Eng; 2018; 29(2):205-215. PubMed ID: 29457594 [TBL] [Abstract][Full Text] [Related]
3. The bio-interface between functionalized Au NR@GO nanoplatforms with protein corona and their impact on delivery and release system. Assali A; Razzazan S; Akhavan O; Mottaghitalab F; Adeli M; Atyabi F Colloids Surf B Biointerfaces; 2019 Jan; 173():891-898. PubMed ID: 30551306 [TBL] [Abstract][Full Text] [Related]
4. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Arnida ; Janát-Amsbury MM; Ray A; Peterson CM; Ghandehari H Eur J Pharm Biopharm; 2011 Apr; 77(3):417-23. PubMed ID: 21093587 [TBL] [Abstract][Full Text] [Related]
5. Orthogonal analysis of functional gold nanoparticles for biomedical applications. Tsai DH; Lu YF; DelRio FW; Cho TJ; Guha S; Zachariah MR; Zhang F; Allen A; Hackley VA Anal Bioanal Chem; 2015 Nov; 407(28):8411-22. PubMed ID: 26362156 [TBL] [Abstract][Full Text] [Related]
6. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles. Liu X; Huang N; Wang H; Li H; Jin Q; Ji J Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246 [TBL] [Abstract][Full Text] [Related]
7. Biocompatible PEGylated gold nanorods as colored contrast agents for targeted in vivo cancer applications. Kopwitthaya A; Yong KT; Hu R; Roy I; Ding H; Vathy LA; Bergey EJ; Prasad PN Nanotechnology; 2010 Aug; 21(31):315101. PubMed ID: 20622303 [TBL] [Abstract][Full Text] [Related]
8. Size- and surface chemistry-dependent pharmacokinetics and tumor accumulation of engineered gold nanoparticles after intravenous administration. Wang J; Bai R; Yang R; Liu J; Tang J; Liu Y; Li J; Chai Z; Chen C Metallomics; 2015 Mar; 7(3):516-24. PubMed ID: 25671498 [TBL] [Abstract][Full Text] [Related]
9. Double phase transfer of gold nanorods for surface functionalization and entrapment into PEG-based nanocarriers. Gentili D; Ori G; Comes Franchini M Chem Commun (Camb); 2009 Oct; (39):5874-6. PubMed ID: 19787126 [TBL] [Abstract][Full Text] [Related]
10. Colloidal stability of gold nanorod solution upon exposure to excised human skin: Effect of surface chemistry and protein adsorption. Mahmoud NN; Al-Qaoud KM; Al-Bakri AG; Alkilany AM; Khalil EA Int J Biochem Cell Biol; 2016 Jun; 75():223-31. PubMed ID: 26923289 [TBL] [Abstract][Full Text] [Related]
11. The importance of the CTAB surfactant on the colloidal seed-mediated synthesis of gold nanorods. Smith DK; Korgel BA Langmuir; 2008 Feb; 24(3):644-9. PubMed ID: 18184021 [TBL] [Abstract][Full Text] [Related]
12. In vivo monitoring of intravenously injected gold nanorods using near-infrared light. Niidome T; Akiyama Y; Shimoda K; Kawano T; Mori T; Katayama Y; Niidome Y Small; 2008 Jul; 4(7):1001-7. PubMed ID: 18581412 [TBL] [Abstract][Full Text] [Related]
13. Graphene oxide-promoted reshaping and coarsening of gold nanorods and nanoparticles. Pan H; Low S; Weerasuriya N; Shon YS ACS Appl Mater Interfaces; 2015 Feb; 7(5):3406-13. PubMed ID: 25611371 [TBL] [Abstract][Full Text] [Related]
14. PEG Quantitation Using Reversed-Phase High-Performance Liquid Chromatography and Charged Aerosol Detection. Smith MC; Clogston JD Methods Mol Biol; 2018; 1682():49-55. PubMed ID: 29039092 [TBL] [Abstract][Full Text] [Related]
15. Protein coronas on gold nanorods passivated with amphiphilic ligands affect cytotoxicity and cellular response to penicillin/streptomycin. Kah JC; Grabinski C; Untener E; Garrett C; Chen J; Zhu D; Hussain SM; Hamad-Schifferli K ACS Nano; 2014 May; 8(5):4608-20. PubMed ID: 24758495 [TBL] [Abstract][Full Text] [Related]
16. Colloidally stable and surfactant-free protein-coated gold nanorods in biological media. Tebbe M; Kuttner C; Männel M; Fery A; Chanana M ACS Appl Mater Interfaces; 2015 Mar; 7(10):5984-91. PubMed ID: 25706195 [TBL] [Abstract][Full Text] [Related]
17. PEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imaging. Zhou B; Yang J; Peng C; Zhu J; Tang Y; Zhu X; Shen M; Zhang G; Shi X Colloids Surf B Biointerfaces; 2016 Apr; 140():489-496. PubMed ID: 26812636 [TBL] [Abstract][Full Text] [Related]
18. Ligand customization and DNA functionalization of gold nanorods via round-trip phase transfer ligand exchange. Wijaya A; Hamad-Schifferli K Langmuir; 2008 Sep; 24(18):9966-9. PubMed ID: 18717601 [TBL] [Abstract][Full Text] [Related]
19. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Cai QY; Kim SH; Choi KS; Kim SY; Byun SJ; Kim KW; Park SH; Juhng SK; Yoon KH Invest Radiol; 2007 Dec; 42(12):797-806. PubMed ID: 18007151 [TBL] [Abstract][Full Text] [Related]
20. PEGylated graphene oxide-capped gold nanorods/silica nanoparticles as multifunctional drug delivery platform with enhanced near-infrared responsiveness. Qi Z; Shi J; Zhang Z; Cao Y; Li J; Cao S Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109889. PubMed ID: 31499943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]